Larson Financial Group’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6
Closed -$1K 1540
2022
Q3
$1K Hold
6
﹤0.01% 1278
2022
Q2
$1K Hold
6
﹤0.01% 1174
2022
Q1
$2K Hold
6
﹤0.01% 945
2021
Q4
$2K Hold
6
﹤0.01% 986
2021
Q3
$2K Hold
6
﹤0.01% 806
2021
Q2
$2K Hold
6
﹤0.01% 744
2021
Q1
$2K Hold
6
﹤0.01% 737
2020
Q4
$2K Hold
6
﹤0.01% 664
2020
Q3
$2K Hold
6
﹤0.01% 625
2020
Q2
$1K Hold
6
﹤0.01% 666
2020
Q1
$1K Buy
+6
New +$996 ﹤0.01% 522
2019
Q3
Sell
-210
Closed -$55K 638
2019
Q2
$55K Buy
210
+10
+5% +$2.65K 0.04% 122
2019
Q1
$57K Buy
+200
New +$66.5K 0.05% 109

Other funds holding ABMD

Larson Financial Group's ABMD Position: Q4 2022 in Review

Larson Financial Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 6 shares — an estimated $1K sold.

Larson Financial Group first reported a position in ABMD in Q1 2019 and held it in 13 quarters. The position peaked at $57K in Q1 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Larson Financial Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Larson Financial Group sold 6 Abiomed Inc shares in Q4 2022, an estimated $1K.
  • Larson Financial Group first reported a position in Abiomed Inc in Q1 2019 and held it in 13 quarters.
  • Larson Financial Group's Abiomed Inc position peaked at $57K in Q1 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Larson Financial Group's 13F filing for Q4 2022, filed 3 Feb 2023.